Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX HELSINKI LTD.  >  Orion Oyj    ORNBV   FI0009014377

ORION OYJ

(ORNBV)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq Omx Helsinki Ltd.
11/18/2020 11/19/2020 11/20/2020 11/23/2020 11/24/2020 Date
38.95(c) 39.58(c) 39.9(c) 39.49(c) 39.25 Last
234 727 393 807 231 689 213 818 70 766 Volume
+0.65% +1.62% +0.81% -1.03% -0.61% Change
More quotes
Financials
Sales 2020 1 088 M 1 294 M 1 294 M
Net income 2020 235 M 279 M 279 M
Net cash position 2020 134 M 159 M 159 M
P/E ratio 2020 23,7x
Yield 2020 3,76%
Sales 2021 1 063 M 1 264 M 1 264 M
Net income 2021 208 M 247 M 247 M
Net cash position 2021 145 M 172 M 172 M
P/E ratio 2021 26,7x
Yield 2021 3,83%
Capitalization 5 551 M 6 557 M 6 598 M
EV / Sales 2020 4,98x
EV / Sales 2021 5,08x
Nbr of Employees 3 320
Free-Float 86,8%
More Financials
Company
Orion is Finland's leading pharmaceutical group. Net sales break down by family products and services as follows: - generic, OTC and biosimilar drugs (46.3%); - patented prescription products (38.6%): notably intended for treating dysfunctions of the nervous system, cardiovascular diseases, hormonal and urological treatments; - animal products (8.2%); - pharmaceutical ingredients (5.2%); - other (1.7%):... 
More about the company
Notations Surperformance© of Orion Oyj
Trading Rating : Investor Rating :
More Ratings
All news about ORION OYJ
11/10ORION OYJ : invests EUR 17 million in its production plants in Turku
PU
10/29ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
PU
10/29ORION OYJ : Prosecutor pressed charges against a member of Orion's Board of Dire..
AQ
10/29Prosecutor pressed charges against a member of Orion's Board of Directors for..
GL
10/21ORION OYJ : Composition of the Nomination Committee of Orion Corporation
PU
10/21ORION OYJ : Composition of the Nomination Committee of Orion Corporation
AQ
10/21Composition of the Nomination Committee of Orion Corporation
GL
10/21ORION OYJ : Finnish drugmaker Orion's third-quarter profit and sales fall
RE
10/21ORION OYJ : Group Interim Report 1-9/2020
PU
10/21ORION OYJ : Group Interim Report 1-9/2020
AQ
10/21Orion Group Interim Report 1-9/2020
GL
10/21ORION OYJ : Press Release
CO
10/19ORION OYJ : upgrades full-year outlook for 2020
AQ
10/19Orion upgrades full-year outlook for 2020
GL
10/19ORION OYJ : statutory co-operation negotiations completed regarding the Research..
PU
More news
News in other languages on ORION OYJ
07/14ORION OYJ : Veröffentlichung des Halbjahresergebnisses
07/14ORION OYJ : publication des résultats semestriels
07/09Les actions hésitantes, la Chine et les résultats en soutien
2019ORION OYJ : publication des résultats trimestriels
2019ORION OYJ : Veröffentlichung des Quartalsergebnisses
More news
Analyst Recommendations on ORION OYJ
More recommendations
Chart ORION OYJ
Duration : Period :
Orion Oyj Technical Analysis Chart | ORNBV | FI0009014377 | MarketScreener
Technical analysis trends ORION OYJ
Short TermMid-TermLong Term
TrendsBullishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 7
Average target price 32,78 €
Last Close Price 39,49 €
Spread / Highest target 6,36%
Spread / Average Target -17,0%
Spread / Lowest Target -29,1%
EPS Revisions
Managers
NameTitle
Timo Antero Lappalainen President & Chief Executive Officer
Heikki Seppo Westerlund Chairman
Satu Maarit Ahomäki Senior Vice President-Commercial Operations
Jari Ilmari Karlson Chief Financial Officer & SVP-Animal Health
Sinikka Markkula Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
ORION OYJ-4.31%6 557
JOHNSON & JOHNSON-1.37%378 744
ROCHE HOLDING AG-3.77%283 004
MERCK & CO., INC.-11.73%203 111
PFIZER INC.-6.79%202 993
NOVARTIS AG-13.38%198 168